Protective effect of nitric oxide synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration

Brain Research

Volumn 1193, Issue , 2008, Pages 120-127

  Delwing, Débora ^a,b   Delwing, Daniela ^a   Bavaresco, Caren S ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Antioxidants; Arginine; Hippocampus; Intracerebroventricular; Na+,K+ ATPase; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA TOCOPHEROL; AMINO ACID; ANTIOXIDANT; ARGININE; ASCORBIC ACID; FREE RADICAL; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIET THERAPY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TOTAL RADICAL TRAPPING ANTIOXIDANT PARAMETER;

ALPHA-TOCOPHEROL; AMIDINES; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; NG-NITROARGININE METHYL ESTER; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 39149112241     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.11.052     Document Type: Article

References (56)

1. Baron M., Kudin A.P., and Kunz W.S. Mitochondrial dysfunction in neurodegenerative disorders. Biochem. Soc. Trans. 35 (2007) 1228-1231
2. +-ATPase inhibition induced by arginine administration is prevented by vitamins E and C. Neurochem. Res. 6 (2003) 825-829
3. Beckman J.S., Carson M., Smith C.D., and Koppenol W.H. ALS, SOD and peroxynitrite. Nature 364 (1993) 584
4. Bradford M.M. A rapid and sensitive method for the quantification of micrograms quantities of protein utilizing the principle of protein die-binding. Anal. Biochem. 72 (1976) 248-254
5. Brusilow S.W., and Horwich A. Urea cycle enzymes. In: Scriver C.R., Beaudet L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th edition (2001), McGraw-Hill, New York 1909-1963
6. Buchmann I., Milakofsky L., Harris N., Hofford J.M., and Vogel W.H. Effect of arginine administration on plasma and brain levels of arginine and various related amino compounds in the rat. Pharmacology 53 (1996) 133-142
7. Buettner G.R. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300 (1993) 535-543
8. Burton G.W., Wronska U., Stone L., Foster D.O., and Ingold K.U. Biokinetics of dietary RRR-α-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids 25 (1990) 199-210
9. Butterfield D.A., and Stadtman E.R. Protein oxidation processes in aging brain. Adv. Cell. Aging Gerontol. 2 (1997) 161-191
10. Carr A., and Frei B. Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J. 13 (1999) 1007-1024
11. 2+-stimulated ATPase activity. Anal. Biochem. 157 (1986) 375-380
12. Darley-Usmar V., Wiseman H., and Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 369 (1995) 131-135
13. Dawson V.L., and Dawson T.M. Nitric oxide in neuronal degeneration. Proc. Soc. Exp. Biol. Med. 211 (1996) 33-40
14. Delwing D., Delwing D., Wannamacher C.M.D., Wajner M., Dutra-Filho C.S., and Wyse A.T.S. Arginine administration reduces catalase activity in midbrain of rats. NeuroReport 13 (2002) 1301-1304
15. Delwing D., Tagliari B., Streck E.L., Wannamacher C.M.D., Wajner M., and Wyse A.T.S. Reduction of energy metabolism in rat hippocampus by arginine administration. Brain Res. 983 (2003) 58-63
16. Delwing D., Tagliari B., Chiarani F., Wannmacher C.M.D., Wajner M., and Wyse A.T.S. α-Tocopherol and ascorbic acid administration prevents the impairment of brain energy metabolism of hyperargininemic rats. Cell. Mol. Neurobiol. 26 (2006) 177-189
17. D' Hooge R., and De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Res. Brain Res. Rev. 36 (2001) 60-90
18. Erecinska M., and Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 43 (1994) 37-71
19. Erecinska M., Cherian S., and Silver I.A. Energy metabolism in mammalian brain during development. Prog. Neurobiol. 73 (2004) 397-445
20. Evelson P., Travacio M., Repetto M., Escobar J., Llesuy S., and Lissi E.A. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch. Biochem. Biophys. 388 (2001) 261-266
21. Flynn N.E., Meininger C.J., Haynes T.E., and Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmacother. 56 (2002) 427-438
22. Frei B., Stocker R., England L., and Ames B.N. Ascorbate: the most effective antioxidant in the blood. Adv. Exp. Med. Biol. 264 (1990) 155-163
23. + pump in epilepsy. Ann. Neurol. 16 (1984) 128-134
24. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-31658
25. Heales S.J.R., Bolaños J.P., Stewart V.C., Brookes P.S., Land J.M., and Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1410 (1999) 215-228
26. Iyer R., Jenkinson C.P., Vockley J.G., Kern R.M., Grody W.W., and Cederbaum S. The human arginases and arginase deficiency. J. Inherit. Metab. Dis. 21 (1998) 86-100
27. ω-nitro-l-arginine methyl ester does not influence lithium-induced c-Fos and conditioned taste aversion. Yonsei Med. J. 44 (2003) 869-874
28. Jones D.H., and Matus A.I. Isolation of plasma synaptic membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta 356 (1974) 276-287
29. Kurella E.G., Tyulina O.V., and Boldyrev A.A. Oxidative resistance of Na/K-ATPase. Cell. Mol. Neurobiol. 19 (1999) 133-140
30. Lees G.J. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54 (1993) 287-322
31. Lipton S.A., Choy Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., Loscalzo J., Singel D.J., and Stamler J.S. A redox-based mechanism for the neuroprotective effects of nitric oxide and related nitroso-compounds. Nature 364 (1993) 626-632
32. Lohse M.J., Forstermann U., and Schmidt H.H.H.W. Pharmacology of NO: cGMP signal transduction. Naunyn-Schmiedeberg's. Arch. Pharm. 358 (1998) 111-112
33. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-267
34. McCay P.B. Vitamin E: interactions with free radical and ascorbate. Annu. Rev. Nutr. 5 (1985) 323-340
35. +, and strophanthidin in vitro. Neurochem. Res. 14 (1989) 845-851
36. Moncada S., and Higgs A. The l-arginine pathway. N. Engl. J. Med. 329 (1993) 2002-2012
37. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am. J. Clin. Nutr. 54 (1991) 1119S-1124S
38. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
40. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
41. +-ATPase activity and impairs retention of an inhibitory avoidance task in rats. Brain Res. 951 (2002) 151-157
42. Reznick A.Z., and Packer L. Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G., Albano E., and Dianzani M.U. (Eds). Free Radicals: From Basic Science to Medicine (1993), Birkhaüser Verlag, Basel 425-437
43. Sandy M.S., DiMonte D., and Smith M.T. Relationships between intracellular vitamin E, lipid peroxidation, and chemical toxicity in hepatocytes. Toxicol. Appl. Pharmacol. 93 (1988) 288-297
44. +)-ATPase activity from porcine cerebral cortex by NO generating drugs. Brain Res. 704 (1995) 117-120
45. Squire L.R. Memory systems of the brain: a brief history and current perspective. Neurobiol. Learn Mem. 82 (2004) 171-177
46. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc.) 67 (2002) 281-292
47. Viani P., Cervato G., Fiorilli A., and Cestaro B. Age-related differences in synaptosomal peroxidative damage and membrane properties. J. Neurochem. 56 (1991) 253-258
48. +-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J. Cell Sci. 116 (2003) 2099-2110
49. Wheller K.P., Walker J.A., and Barker D.M. Lipid requirement of the membrane sodium-plus-potassium ion-dependent adenosine triphosphatase system. Biochem. J. 146 (1975) 713-722
50. +-ATPase activity in the synaptic plasma membrane from the central cerebral cortex of rats subjected to chemically induced phenylketonuria. Med. Sci. Res. 23 (1995) 261-262
51. +-ATPase activity after brain ischemia. Neurochem. Res. 25 (2000) 969-973
52. +-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem. Res. 26 (2001) 515-520
53. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27 (2002) 1685-1689
54. Yang Y.B., and Piao Y.J. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol. Sin. 24 (2003) 703-710
55. +-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death. Biochem. Pharmacol. 66 (2003) 1601-1609
56. +-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage. Neurochem. Res. 16 (1993) 1033-1039